American Academy of CME

Best of ACTHIV 2022: Case-Based Management of Hepatitis C in Persons with HIV

Overview / Abstract:	At the completion of this educational activity, participants will: Discuss pre-treatment Assessment, recommended regimens and on-treatment monitoring for simplified HCV treatment Discuss some real-world HCV treatment issues related to choice of direct-acting antiviral (DAA) therapy in HIV-HCV coinfected patients Identify relevant drug interactions of DAAs with antiretroviral therapy
Expiration	Sep 15, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Online
Credits / Hours	.75
Accreditation	AMA, AAPA, ANCC
Presenters / Authors / Faculty	Oluwaseun Falade-Nwulia, MBBS, MPH Assistant Professor of Medicine Johns Hopkins University School of Medicine
Activity Specialities / Related Topics	HIV / AIDS, Infectious Disease
Sponsors / Supporters / Grant Providers	Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck, Theratechnologies, and ViiV Healthcare
Keywords / Search Terms	American Academy of CME HIV AIDS HCV direct-acting antiviral (DAA) therapy HIV-HCV coinfected patients Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map